NCSYF
NICE Ltd.
$90.25
+1.44%
No data for this timeframe.
Vol
SEC Reports5
Recent Activity
Jun 9, 2026
SEC
NICE Ltd. reported that at its Special General Meeting on June 9, 2026, shareholders approved all proposals. This is a r
6-K — Impact 2/10
Jun 9, 2026
SEC
NICE Ltd. filed a 6-K announcing two strategic partnerships: (1) a joint solution with ServiceNow integrating CXone with
6-K — Impact 4/10
May 6, 2026
SEC
NICE Ltd. reported Q1 2026 results with total revenue of $768.6M (+9.8% YoY) and cloud revenue of $603.4M (+14.6% YoY),
6-K — Impact 6/10
Analyst Ratings
4Strong Buy
6Buy
6Hold
0Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 1 mixed, 3 neutral. Avg impact: 4.0/10.
NEUTRAL
6-K
2/10
NICE Ltd. reported that at its Special General Meeting on June 9, 2026, shareholders approved all pr
Jun 9, 2026
NEUTRAL
6-K
4/10
NICE Ltd. filed a 6-K announcing two strategic partnerships: (1) a joint solution with ServiceNow in
Jun 9, 2026
MIXED
6-K
6/10
NICE Ltd. reported Q1 2026 results with total revenue of $768.6M (+9.8% YoY) and cloud revenue of $6
May 6, 2026
NEUTRAL
6-K
1/10
NICE Ltd. filed a 6-K to reschedule its special general meeting from May 28, 2026 to June 2, 2026 du
Apr 30, 2026
BULLISH
6-K
7/10
NICE Ltd. announced a suite of breakthrough Agentic AI innovations at Nexus 2026 and Enterprise Conn
Apr 9, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 63% buy across 16 analysts — 4 strong buy, 6 buy, 6 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.8B | 5.5% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.8B | 8.7% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $3.2B | 7.9% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $3.5B | 9.7% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 6 | 6 | 0 | 0 | 63% | |
| May 1, 2026 | 4 | 6 | 6 | 0 | 0 | 63% | |
| Apr 1, 2026 | 4 | 6 | 6 | 0 | 0 | 63% | |
| Mar 1, 2026 | 4 | 6 | 6 | 0 | 0 | 63% | |
| Feb 1, 2026 | 4 | 6 | 6 | 0 | 0 | 63% | |
| Jan 1, 2026 | 4 | 6 | 6 | 0 | 0 | 63% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.